Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,788,796
+$1,236,437 QoQ
Shares Held
38,900
-1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#929
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWER BRIDGE ADVISORS holds $63,752,721 across 8 Drug Manufacturers - General names. ABBV ranks #3 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,561 | $22,745,806 | |
| 2 | NVS |
Novartis AG
|
69,416 | $10,878,875 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
38,900 | $9,788,796 | |
| 4 | LLY |
ELI LILLY & Co
|
6,601 | $7,917,438 | |
| 5 | AMGN |
Amgen Inc
|
15,102 | $5,468,736 | |
| 6 | MRK |
Merck & Co., Inc.
|
34,852 | $4,478,482 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
26,527 | $1,528,485 | |
| 8 | PFE |
Pfizer Inc
|
39,290 | $946,103 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,788,796 | 38,900 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $8,552,359 | 39,323 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,144,855 | 40,023 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,285,911 | 40,105 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,446,703 | 40,118 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $8,376,190 | 39,978 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $7,121,860 | 40,078 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $7,899,792 | 40,003 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $6,535,426 | 38,103 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $6,938,556 | 38,103 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $6,460,079 | 41,686 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,236,372 | 41,838 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $5,598,166 | 41,551 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $8,828,938 | 55,399 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $9,111,410 | 56,379 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $7,606,888 | 56,679 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,918,200 | 58,228 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $10,058,763 | 62,049 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $8,171,254 | 60,349 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $6,934,530 | 64,286 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $6,967,234 | 61,854 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $6,213,343 | 57,414 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $5,752,562 | 53,687 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,393,133 | 27,322 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,673,637 | 27,232 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $2,080,139 | 27,302 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||